Sort
50,496 grants matching “lung cancer”
PROMINENT - IARC
$450,879Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2023 · CA
FRESH: Dual Home Screening for Lung Cancer Prevention
$450,790Ellen J Hahn · University Of Kentucky · R01 · FY2012 · ES
Mechanisms of Dual Inhibition of TGFbeta/PD-L1 in HNSCC
$450,789Xiao-Jing Wang · University Of California At Davis · R01 · FY2022 · DE
Trajectories and Palliation Study (TAPS)
$450,753Karl Lorenz · Rand Corporation · R01 · FY2011 · NR
Molecular and cellular mechanism of IL-17 signaling in tumorigenesis
$450,732Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · CA
Molecular and cellular mechanism of IL-17 signaling in tumorigenesis
$450,731Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2018 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$450,696Chao Cheng · Baylor College Of Medicine · R01 · FY2025 · CA
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS
$450,691Paul Joseph Brennan · International Agency For Res On Cancer · R01 · FY2010 · CA
Regulation of MLK3 by LATS
$450,666Deborah N Chadee · University Of Toledo · R15 · FY2019 · CA
Project 1: Targeting the Neutrophil Lineage To Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC
$450,659A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2020 · CA
Laboratory of Cancer Biology and Genetics Microscopy Core Facility
$450,641Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
A lung cancer symptom assessment and management intervention
$450,638Mary E Cooley · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy
$450,637Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2008 · CA
Community Outreach and Engagement
$450,568Anita Y Kinney · Rutgers Biomedical And Health Sciences · P30 · FY2024 · CA
The role of wild-type KRAS in the context of tumor profession and metastasis
$450,563Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2018 · CA
Aberrant megakaryopoiesis in the myeloproliferative neoplasms.
$450,538John D Crispino · Northwestern University At Chicago · R01 · FY2019 · HL
Disruption of the circadian clock in lung cancer
$450,531Brian James Altman · University Of Rochester · R01 · FY2025 · CA
Cancer and Leukemia Group B - The Ohio State University
$450,518Clara D Bloomfield · Ohio State University · U10 · FY2008 · CA
Extracellular ATP in cancer: mechanism study of ATP internalization and ATP-induced drug resistance in cancer cells and tumors
$450,487Xiaozhuo Chen · Ohio University Athens · R15 · FY2019 · CA
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood
$450,480Abhijit Patel · Yale University · U01 · FY2020 · CA
MCG Minority-Based Community Clinical Oncology Program
$450,477Anand P Jillella · Augusta University · U10 · FY2007 · CA
The Metastatic Cascade: Macrophages Lead the Way
$450,456Jeffrey W. Pollard · Albert Einstein College Of Medicine · R01 · FY2013 · CA
MUC1-C is a target for advancing immunotherapy of non-small cell lung cancer
$450,429Donald W. Kufe · Dana-Farber Cancer Inst · R21 · FY2024 · CA
A trial of Positively Smoke Free group therapy for HIV-infected smokers
$450,373Jonathan Shuter · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DA
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
$450,366Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA